Tilgængelige data tyder på, at kvinder måske har 30% lavere tilsyneladende sunitinibclearance (CL/ F) end mænd; denne forskel kræver imidlertid ingen dosisjustering.
Available data indicate that females could have about 30% lower apparent clearance (CL/ F) of sunitinib than males: this difference however does not necessitate dose adjustments.